Sharon Bio-Medicine is currently trading at Rs 21.50, up by 1.45 points or 7.23% from its previous closing of Rs 20.05 on the BSE.
The scrip opened at Rs. 20.20 and has touched a high and low of Rs 21.50 and Rs. 18.50 respectively. So far 236732 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 90.20 on 15-Sep-2014 and a 52 week low of Rs. 15.40 on 27-Feb-2015.
Last one week high and low of the scrip stood at Rs. 22.40 and Rs. 19.35 respectively. The current market cap of the company is Rs. 219.06 crore.
The promoters holding in the company stood at 59.25% while Institutions and Non-Institutions held 1.36% and 39.39% respectively.
Sharon Bio-Medicine has received the certification for the approval of Good Manufacturing Practices (GMP) for both, Capsules and Tablets from United Kingdom - Medical & Health Care Product Regulatory Agency (UKMHRA) for its expanded area of Formulation and Tablets unit located at Selaqui, Uttarakhand.
In the view of the above it should be noted that after the expansion, the production capacity of the company’s Formulation and Tablets plant located at Selaqui, Uttarakhand has been doubled in the term of production.
Sharon Bio-Medicine is into manufacturing and supply of Active Pharmaceutical Ingredients (APIs).
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |